Atossa Therapeutics Inc. (ATOS)
NASDAQ: ATOS
· Real-Time Price · USD
0.83
0.01 (0.86%)
At close: Sep 24, 2025, 3:59 PM
0.83
0.79%
After-hours: Sep 24, 2025, 07:11 PM EDT
0.86% (1D)
| Bid | 0.81 |
| Market Cap | 106.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -28.72M |
| EPS (ttm) | -0.22 |
| PE Ratio (ttm) | -3.75 |
| Forward PE | -2.97 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.87 |
| Volume | 399,523 |
| Avg. Volume (20D) | 1,096,652 |
| Open | 0.83 |
| Previous Close | 0.82 |
| Day's Range | 0.82 - 0.85 |
| 52-Week Range | 0.55 - 1.66 |
| Beta | 1.10 |
| Ex-Dividend Date | n/a |
About ATOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+13.14%
Atossa Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
4 months ago · accessnewswire.com
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines f...